Adam Feinstein is the Managing Partner of Vesey Street Capital Partners. Mr. Feinstein has 30 years of investment experience exclusively in the healthcare services sector. Prior to founding Vesey Street Capital Partners in 2014, he was a Managing Director on Wall Street and a healthcare industry executive. He held the position of Senior Vice President of Corporate Development, Strategic Investments, and Office of the Chief Executive Officer at LabCorp. Before his tenure at LabCorp, he spent 14 years as the Managing Director in Equity Research at Lehman Brothers/Barclays Capital. Mr. Feinstein is the Chairman of VSCP's investment committee. He is also actively involved in working with portfolio company executives and sourcing new investment opportunities. At the same time, he oversees all of the firm's investment activities and employees.

Mr. Feinstein's footprint in the industry is notable, as he is currently the Lead Director of AirSculpt Technologies (NASDAQ: AIRS), ScribeAmerica, Safecor Health, GastroMD, Inceptua, and PathGroup. Previously, Adam served on the board of QualityMetric, Imedex, and Surgery Partners (NASDAQ: SGRY).

From his extensive experience at Lehman Brothers and LabCorp, Mr. Feinstein has cultivated invaluable relationships within the industry. He achieved the top ranking in the Institutional Investor All-America Research Survey for the Health Care Facilities category for 8 consecutive years. Adam is a CFA charter holder with a B.S. in Business from the Smith School at the University of Maryland. Additionally, he was a member of the Inaugural Class of Nashville's Healthcare Council Fellows program.